tiprankstipranks
Trending News
More News >
C'BON COSMETICS Co., Ltd. (JP:4926)
:4926
Japanese Market

C'BON COSMETICS Co., Ltd. (4926) AI Stock Analysis

Compare
0 Followers

Top Page

JP

C'BON COSMETICS Co., Ltd.

(4926)

Rating:45Neutral
Price Target:
C'BON COSMETICS Co., Ltd.'s overall stock score is low due to significant financial challenges, including declining revenues and persistent losses impacting cash flow and profitability. Technical analysis supports a bearish outlook with weak momentum, and the valuation is hampered by negative earnings, despite a moderate dividend yield.

C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)

C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model

Company DescriptionC'BON COSMETICS Co.,Ltd. manufactures and sells cosmetics, quasi-drugs, and beauty appliance products. It offers various products, such as cleansing, lotion, cream, face wash, serum, and makeup base products. The company was founded in 1966 and is headquartered in Kawasaki, Japan.
How the Company Makes MoneyC'BON COSMETICS Co., Ltd. generates revenue through the direct sale of its cosmetics products, which include skincare creams, lotions, and other personal care items. The company primarily sells its products through a network of retail stores, online platforms, and beauty salons. Revenue is largely driven by consumer demand for high-quality skincare solutions and the company's ability to maintain strong relationships with retail partners. Additionally, C'BON COSMETICS may engage in strategic partnerships with other brands or entities to expand its market reach and enhance its product offerings. The company's earnings are significantly influenced by its brand reputation, product innovation, and effective marketing strategies.

C'BON COSMETICS Co., Ltd. Financial Statement Overview

Summary
C'BON COSMETICS Co., Ltd. is encountering financial difficulties, with declining revenues and persistent losses. Despite a strong gross profit margin and no debt, the company faces significant challenges with negative cash flow and low profitability, necessitating strategic improvements.
Income Statement
45
Neutral
C'BON COSMETICS Co., Ltd. has experienced declining revenue from 2020 to TTM 2024, with a notable drop in net income, resulting in negative net profit margins. The gross profit margin has remained strong, indicating efficient production, but EBIT and EBITDA margins are weak, reflecting operating challenges.
Balance Sheet
70
Positive
The company maintains a solid equity base with no current debt, resulting in a favorable debt-to-equity ratio. However, there has been a downward trend in stockholders' equity over recent periods, and the return on equity is negative due to consistent net losses.
Cash Flow
30
Negative
The company's cash flow position is concerning, with negative free cash flow and inconsistent operating cash flow. The lack of free cash flow growth and an inability to generate cash from operations suggest financial instability.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue8.60B8.84B8.50B8.53B9.15B9.10B
Gross Profit6.51B6.74B6.40B6.34B7.10B6.92B
EBITDA113.47M292.59M168.64M-92.22M329.61M-345.64M
Net Income-64.47M136.27M-26.35M-421.77M44.87M-621.87M
Balance Sheet
Total Assets8.77B8.52B8.81B8.84B9.56B9.56B
Cash, Cash Equivalents and Short-Term Investments2.71B2.65B3.63B3.98B2.80B2.32B
Total Debt0.000.004.24M13.27M22.30M25.20M
Total Liabilities3.23B2.82B3.15B3.13B3.36B1.97B
Stockholders Equity5.54B5.70B5.66B5.71B6.20B7.60B
Cash Flow
Free Cash Flow0.00-926.52M-313.38M-700.71M321.35M-829.87M
Operating Cash Flow0.00-43.16M278.19M-81.47M433.37M-694.00M
Investing Cash Flow0.00-849.16M-581.94M1.35B44.91M161.38M
Financing Cash Flow0.00-90.22M-31.20M-91.29M-6.73M-6.80M

C'BON COSMETICS Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1126.00
Price Trends
50DMA
1121.96
Positive
100DMA
1121.69
Positive
200DMA
1136.48
Negative
Market Momentum
MACD
0.91
Positive
RSI
48.07
Neutral
STOCH
44.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Negative. The current price of 1126 is below the 20-day moving average (MA) of 1128.45, above the 50-day MA of 1121.96, and below the 200-day MA of 1136.48, indicating a neutral trend. The MACD of 0.91 indicates Positive momentum. The RSI at 48.07 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4926.

C'BON COSMETICS Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥148.24B18.50
5.18%1.51%5.48%
65
Neutral
$27.33B15.36-4.01%3.14%1.00%1.98%
64
Neutral
¥2.23B10.31
1.89%17.16%-45.67%
63
Neutral
¥1.73B
7.97%-117.52%
61
Neutral
¥6.19B10.74
2.44%-2.13%
52
Neutral
¥7.22B176.82
1.33%-7.66%
45
Neutral
¥4.82B35.38
1.78%0.10%-239.09%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4926
C'BON COSMETICS Co., Ltd.
1,126.00
-247.69
-18.03%
JP:4918
Ivy Cosmetics Corporation
330.00
-37.00
-10.08%
JP:4920
Nippon Shikizai, Inc.
1,060.00
-497.09
-31.92%
JP:4925
HABA Laboratories, Inc.
1,637.00
-316.94
-16.22%
JP:4928
Noevir Holdings Co., Ltd.
4,340.00
-1,136.51
-20.75%
JP:4929
ADJUVANT HOLDINGS CO., LTD.
899.00
30.72
3.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 23, 2025